Joel Baglole

Joel Baglole

Joel Baglole has been a financial reporter for more than 20 years. For five years, Mr. Baglole was a staff reporter at The Wall Street Journal, where he wrote articles from Iceland to Indonesia and covered topics ranging from the automotive and airline industries to investment banks and global stock markets.

Mr. Baglole has also worked for The Washington Post and Toronto Star newspapers, and has contributed to business focused websites such as The Motley Fool and Investopedia. At InvestorPlace, he covers a wide range of large and small cap stocks, as well as political and economic issues that impact financial markets.

Check out Joel’s TipRanks profile.

Recent Articles

Is DNA Stock a Buy After Earnings? 3 Analysts Weigh In on Gingko Bioworks.

DNA stock is bouncing higher following a better-than-expected earnings report and strong forward guidance from Gingko Bioworks.

3 Seriously Undervalued Stocks to Buy Before They Go Sky High

A lot of stocks have fallen 50% or more since last November, creating some great bargains that investors should now capitalize on.

Crypto Mining Stocks News: Why Are MARA, RIOT, HUT, BITF, NILE, BTBT Stocks Up Today?

Cryptocurrency mining stocks are rallying on positive news from the European Union and a bullish analyst note.

Why Is Sea Limited (SE) Stock in the Spotlight Today?

SE stock is in focus today as Sea Limited shared further evidence that its international expansion plans have hit roadblocks.

Moderna’s Stock Needs a Shot in the Arm

While MRNA stock has been trending higher in recent weeks, questions remain about Moderna's pipeline and senior management team.